Ultra Market Research | Canada In Vitro Fertilization (IVF) Service Market
The Canadian IVF market faces challenges such as high costs, limited public funding, and ethical considerations. However, opportunities exist in personalized medicine, genetic testing, and the develop

Canada In Vitro Fertilization (IVF) Service Market

  • Report ID : 959

  • Category : Canada

  • No Of Pages : 110

  • Published on: January 2025

  • Status: Published

  • Format : Power Point PDF Excel Word

Key Question Answer

check-box

Global Market Outlook

check-box

In-depth analysis of global and regional trends

check-box

Analyze and identify the major players in the market, their market share, key developments, etc.

check-box

To understand the capability of the major players based on products offered, financials, and strategies.

check-box

Identify disrupting products, companies, and trends.

check-box

To identify opportunities in the market.

check-box

Analyze the regional penetration of players, products, and services in the market.

check-box

Comparison of major players financial performance.

check-box

Evaluate strategies adopted by major players.

check-box

Recommendations

Canada In Vitro Fertilization (IVF) Service Market

 

Introduction

The Canada In Vitro Fertilization (IVF) Service Market is an important segment of the healthcare industry that deals with assisted reproductive technologies (ART) to assist individuals and couples in conceiving. IVF is a procedure where an egg is fertilized with sperm outside the body, and then it is implanted into the uterus. Applications include treating infertility issues, fertility preservation for cancer patients, and enabling parenthood for same-sex couples. Recent trends show increased demand due to rising infertility rates, delayed parenthood, and technological advancements like time-lapse embryo monitoring. In 2024, the market is estimated to be valued at USD 500 million and is projected to grow at a compound annual growth rate (CAGR) of 7.5% over the next five years. This growth is driven by increased awareness and government initiatives to make fertility treatments more accessible.

 

Segmentation

Technology

  • Conventional IVF 
    • Fresh Embryo Transfer 
      • Blastocyst Transfer
      • Day-3 Transfer
      • Others
    • Frozen Embryo Transfer 
      • Vitrification Technology
      • Cryopreservation Protocols
  • ICSI (Intracytoplasmic Sperm Injection) 
    • Sperm Selection Techniques
    • Assisted Hatching

End-User

  • Hospitals  
    • Public Hospitals
    • Private Hospitals
  • Fertility Clinics 
    • Standalone Clinics
    • Chain Clinics
  • Research Institutes 
    • Academic Institutions
    • Private Research Facilities

Service Type

  • Fertility Assessment Services 
    • Hormonal Evaluation
    • Ovarian Reserve Testing
    • Others
  • Treatment Services 
    • IVF Cycles
    • Egg/Sperm Donation
  • Consultation Services 
    • Genetic Counseling
    • Emotional Support

Patient Type

  • Male Infertility 
    • Low Sperm Count
    • Structural Abnormalities
  • Female Infertility 
    • Ovarian Dysfunction
    • Tubal Blockage

 

List of Market Players

CReATe Fertility Centre (Canada)

Toronto Centre for Advanced Reproductive Technology (Canada)

Anova Fertility & Reproductive Health (Canada)

Mount Sinai Fertility (Canada)

Olive Fertility Centre (Canada)

PCRM Fertility Clinic (Canada)

Trio Fertility (Canada)

Repromed Ltd. (Canada)

Victoria Fertility Centre (Canada)

McGill Reproductive Centre (Canada)

Procrea Fertility (Canada)

London Health Sciences Centre (Canada)

Medcan Fertility (Canada)

Orchard International Inc. (Canada)

Fertilys (Canada)

 

Drivers

The Canada In Vitro Fertilization (IVF) Service Market is growing rapidly, mainly because of the rising rates of infertility due to lifestyle factors, late marriages, and environmental issues. Improved embryo freezing methods and genetic testing further increase the success rate of IVF, making it a popular choice. Government policies, such as partial funding in some provinces, also make the treatment more affordable and accessible. There are also rising awareness campaigns and support for LGBTQ+ couples. In addition, the number of single parents who are choosing IVF is on the rise, which reflects changing societal norms.

Restraints

Despite the promising growth, the market is challenged by the high cost of treatment, limited insurance coverage, and unequal access across Canada. Many rural areas lack specialized fertility clinics, thus creating geographic disparities in service availability. Ethical concerns over embryo manipulation and cultural stigmas around infertility treatments also discourage adoption. The physical and emotional toll of IVF procedures, combined with inconsistent success rates, can discourage potential patients from pursuing treatment.

 

Opportunity

Innovations such as AI-driven embryo selection, personalized IVF treatments, and minimally invasive techniques will open up new opportunities in the market. Expanding telemedicine services can bridge the urban-rural divide, providing consultations to remote areas. Cross-border medical tourism targeting patients from the U.S. seeking affordable and high-quality services is another growth avenue. Collaborations between fertility centers and pharmaceutical companies for research and development of advanced fertility drugs can further enhance market potential. Government support for subsidized treatments also opens doors for underserved demographics.

 

Trend

The latest trend in the Canada In Vitro Fertilization (IVF) Service Market is integrating digital tools such as wearable devices and mobile applications to monitor and optimize fertility treatments. AI and machine learning revolutionize embryo selection and improve predictive analytics for treatment outcomes. Social egg freezing is a growing trend as more and more career-driven people delay starting their families. In addition, eco-friendly practices in IVF centers, such as sustainable lab operations, are emerging as a focus area. Collaboration with genetic research initiatives enables tailored fertility solutions, which is in line with personalized medicine.

 

Approved Products and Pipeline

  • Gonal-f (Follitropin alfa)
  • Puregon (Follitropin beta)
  • Menopur (Menotropins)
  • Cetrotide (Cetrorelix)
  • Orgalutran (Ganirelix)
  • Ovidrel (Choriogonadotropin alfa)
  • Bemfola (Follitropin alfa biosimilar)
  • Rekovelle (Follitropin delta)

 

Key Target Audience

  • Fertility Clinics
  • Hospitals
  • Pharmaceutical Companies
  • Research Institutes
  • Policy Makers
  • Healthcare Providers
  • Patients and Caregivers
  • Medical Device Manufacturers
  • Investors

 

Frequently Aasked Questions (FAQ's)

It encompasses services and technologies facilitating assisted reproduction, such as IVF treatments and fertility assessments.
Rising infertility rates, technological advancements, and supportive government policies.
High costs, limited access, and ethical concerns.
Key players include CReATe Fertility Centre, Mount Sinai Fertility, and Olive Fertility Centre.
Adoption of AI, digital tools, social egg freezing, and eco-friendly practices in fertility centers.

Choose License Type

  • $3999

  • $5550

  • $6999

Our Reports Look Like This

Ultra Market Research

HAVE A QUESTION

will help you find what you are looking for:


Related Reports

Recent Reports

Subscribe to Newsletter

Provide your email to get email notification when we publish new reports.

whatsapp